BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17462625)

  • 1. Anti-fibrotic effect of meloxicam in a murine lung fibrosis model.
    Arafa HM; Abdel-Wahab MH; El-Shafeey MF; Badary OA; Hamada FM
    Eur J Pharmacol; 2007 Jun; 564(1-3):181-9. PubMed ID: 17462625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol alleviates bleomycin-induced lung injury in rats.
    Sener G; Topaloğlu N; Sehirli AO; Ercan F; Gedik N
    Pulm Pharmacol Ther; 2007; 20(6):642-9. PubMed ID: 17035056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats.
    Altintas N; Erboga M; Aktas C; Bilir B; Aydin M; Sengul A; Ates Z; Topcu B; Gurel A
    Inflammation; 2016 Feb; 39(1):65-78. PubMed ID: 26253295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effects of meloxicam on cardiotoxicity and antitumor activity of doxorubicin in mice.
    Hassan MH; El-Beshbishy HA; Aly H; Attia SM; Bahashwan SA; Ghobara MM
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):559-69. PubMed ID: 25053391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice.
    Shariati S; Kalantar H; Pashmforoosh M; Mansouri E; Khodayar MJ
    Biomed Pharmacother; 2019 Jun; 114():108776. PubMed ID: 30903918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study.
    Villegas I; Martín MJ; La Casa C; Motilva V; De La Lastra CA
    Free Radic Res; 2002 Jul; 36(7):769-77. PubMed ID: 12180128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of food intake and oxidative stress on intestinal lesions caused by meloxicam and piroxicam in rats.
    Villegas I; Alarcón de la Lastra C; La Casa C; Motilva V; Martín MJ
    Eur J Pharmacol; 2001 Feb; 414(1):79-86. PubMed ID: 11230998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats.
    Iraz M; Erdogan H; Kotuk M; Yağmurca M; Kilic T; Ermis H; Fadillioğlu E; Yildirim Z
    Pharmacol Res; 2006 Mar; 53(3):310-6. PubMed ID: 16459098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats.
    Sogut S; Ozyurt H; Armutcu F; Kart L; Iraz M; Akyol O; Ozen S; Kaplan S; Temel I; Yildirim Z
    Eur J Pharmacol; 2004 Jun; 494(2-3):213-20. PubMed ID: 15212977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats.
    Yao HW; Zhu JP; Zhao MH; Lu Y
    Respiration; 2006; 73(2):236-42. PubMed ID: 16330873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice.
    Chilakapati SR; Serasanambati M; Manikonda PK; Chilakapati DR; Watson RR
    Can J Physiol Pharmacol; 2014 Aug; 92(8):631-9. PubMed ID: 24933624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Protective Effect of Naringin against Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats.
    Turgut NH; Kara H; Elagoz S; Deveci K; Gungor H; Arslanbas E
    Pulm Med; 2016; 2016():7601393. PubMed ID: 26977316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.
    Kalayarasan S; Sriram N; Sudhandiran G
    Life Sci; 2008 Jun; 82(23-24):1142-53. PubMed ID: 18462759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
    Verma R; Brahmankar M; Kushwah L; Suresh B
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model.
    Iyer SN; Margolin SB; Hyde DM; Giri SN
    Exp Lung Res; 1998; 24(1):119-32. PubMed ID: 9457473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
    El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
    Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive effect of melatonin on bleomycin-induced lung fibrosis in rats.
    Yildirim Z; Kotuk M; Erdogan H; Iraz M; Yagmurca M; Kuku I; Fadillioglu E
    J Pineal Res; 2006 Jan; 40(1):27-33. PubMed ID: 16313495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of meloxicam on oxygen radical generation in rat gastric mucosa.
    Villegas I; Martín MJ; La Casa C; Motilva V; Alarcón de la Lastra C
    Inflamm Res; 2000 Jul; 49(7):361-6. PubMed ID: 10959558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase-5 inhibition by sildenafil citrate in a rat model of bleomycin-induced lung fibrosis.
    Yildirim A; Ersoy Y; Ercan F; Atukeren P; Gumustas K; Uslu U; Alican I
    Pulm Pharmacol Ther; 2010 Jun; 23(3):215-21. PubMed ID: 19945540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of COX-2 inhibitor meloxicam against traumatic brain injury-induced biochemical, histopathological changes and blood-brain barrier permeability.
    Hakan T; Toklu HZ; Biber N; Ozevren H; Solakoglu S; Demirturk P; Aker FV
    Neurol Res; 2010 Jul; 32(6):629-35. PubMed ID: 19660237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.